Vimarsana
Biggest News Aggregation in the World

Page 2 - Data Expected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Expected Today - Breaking & Trending Today

New Guidance on Cosmetic Ingredient Testing And Evaluation - Vimarsana News

New Guidance on Cosmetic Ingredient Testing And Evaluation

The SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation includes section on special consideration for certain cosmetic ingredients, including nanomaterials. It Defines nanomaterials, potential safety issues and requires safety data

SCCS Updates Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation | Bergeson & Campbell, P.C. - Vimarsana News

SCCS Updates Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation | Bergeson & Campbell, P.C.

The European Commission’s (EC) Scientific Committee on Consumer Safety (SCCS) published on May 16, 2023, the 12th revision of The SCCS Notes of Guidance for the Testing of Cosmetic...

Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned Researchers Drs. Christine Seidman and Alex Marson... | May 10, 2023

Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today Three Additional Data Announcements Expected in 2023Completed Enrollment in Phase 2b VOYAGE Study of VK2809 for NASH and Fibrosis; Data Expected in... | April 26, 2023

Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update - Vimarsana News

Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...